taglich brothers

In a report published Thursday, Taglich Brothers analyst Juan Noble reiterated a Speculative Buy rating on CollabRx (NASDAQ: CLRX), but lowered the price target from $7.00 to $1.85. In the report, Taglich Brothers noted, “Reiterate Speculative Buy but lowering (12-month) price target to $1.85 per...

In a report published Tuesday, Taglich Brothers analyst Juan Noble reiterated a Buy rating on Novadaq Technologies (NASDAQ: NVDQ), but lowered the price target from $19.00 to $16.50. In the report, Taglich Brothers noted, “Reiterating Buy but lowering (12-month) price target to $16.50 from $19.00...

In a report published Friday, Taglich Brothers analyst Howard Halpern reiterated a Speculative Buy rating and $24.50 price target on AeroCentury (NYSE: ACY). In the report, Taglich Brothers noted, “Maintaining Speculative Buy and 12-month price target of $24.50. Current customers are stronger...

In a report published Friday, Taglich Brothers analyst Juan Noble reiterated a Speculative Buy rating and $1.85 price target on Command Security Corporation (NYSE: MOC). In the report, Taglich Brothers noted, “Reiterate Speculative Buy rating and maintaining (12-month) price target of $1.85 per...

In a report published on Friday, Taglich Brothers downgraded its rating on HCI Group (NYSE: HCI) from Buy to Speculative Buy. Taglich Brothers also raised its price target on the company from $31.95 to $38. In the report analyst Howard Halpern commented that, "We lowered our rating due to share...

In a report published Tuesday, Taglich Brothers analyst Howard Halpern reiterated a Speculative Buy rating on Lifeway Foods (NASDAQ: LWAY), and raised the price target from $11.50 to $14.10. In the report, Halpern noted, “Maintaining our Speculative Buy rating. LWAY's brand awareness campaign...

Taglich Brothers initiated CEL-SCI Corporation (NYSE: CVM) with a Speculative Buy rating. Taglich Brothers commented, "If Multikine secures regulatory clearance and launches in the US and Western Europe by 2018, it should, with relatively modest market penetration and a price per treatment of $50,...

In a report published Friday, Taglich Brothers reiterated its Speculative Buy rating on Sonic Foundry (NASDAQ: SOFO), but lowered its price target from $12.25 to $10.50. Taglich Brothers noted, “Maintaining Speculative Buy rating. Reducing our (12-month) price target to $10.50 from $12.25 per...

Taglich Brothers reduced its rating on Amtech Systems (NASDAQ: ASYS) from Speculative Buy to Neutral. Taglich Brothers noted, "Solar industry manufacturers should experience a second year of uncertainty with many tier 2 and tier 3 manufactures likely to shut down in 2013. Tier 1 manufacturers...

In a report published Wednesday, Taglich Brothers reiterated its Speculative Buy rating on Radiant Logistics (NYSEAMEX: RLGT), but slightly lowered its price target from $2.85 to $1.85. Taglich Brothers noted, “Maintaining Speculative Buy rating. Lowering our (12-month) price target to $1.85 from...

In a report published Wednesday, Taglich Brothers reiterated its Speculative Buy rating and $11.50 price target on Lifeway Foods (NASDAQ: LWAY). Taglich Brothers noted, “Maintaining our Speculative Buy rating and $11.50 12-month price target. LWAY's brand awareness campaign boosted its 2011 sales...

Taglich Brothers reiterated its Buy rating on Novadaq Technologies (NASDAQ: NVDQ) and increased its price target from $11 to $13.25. Taglich Brothers commented, "Reconstructive, cardiac and urological surgery markets have been penetrated to an extent that has made Novadaq cash flow positive....

Taglich Brothers initiated Coverage on Alico (NASDAQ: ALCO) with a Speculative Buy and a $35 price target. Taglich Brothers noted, "Shares of ALCO currently trade at a multiple of 1.9X TTM sales, near its average of 2X over the past three years. A comparison group of 10 farm products companies...

Taglich Brothers reduces its rating on Flexible Solutions International (NYSE: FSI) from a Speculative Buy to Neutral. Taglich Brothers notes, "Lowering to Neutral from Speculative Buy. Believe the stock is fairly valued at the current price. We believe the economic advantage of using TPA as an...